Carcinoma, Ductal, Breast

"Carcinoma, Ductal, Breast" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.

Descriptor ID	D018270
MeSH Number(s)	C04.557.470.200.025.232.500 C04.557.470.615.132.500 C04.588.180.390 C17.800.090.500.390
Concept/Terms	Carcinoma, Ductal, Breast Carcinoma, Ductal, Breast Carcinoma, Invasive Ductal, Breast Invasive Ductal Carcinoma, Breast Carcinoma, Infiltrating Duct Carcinomas, Infiltrating Duct Carcinoma, Mammary Ductal Carcinoma, Mammary Ductal Carcinomas, Mammary Ductal Mammary Ductal Carcinomas Mammary Ductal Carcinoma

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Ductal, Breast".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]
Carcinoma, Ductal [C04.557.470.200.025.232]
Carcinoma, Ductal, Breast [C04.557.470.200.025.232.500]
Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
Carcinoma, Ductal [C04.557.470.615.132]
Carcinoma, Ductal, Breast [C04.557.470.615.132.500]
Neoplasms by Site [C04.588]
Breast Neoplasms [C04.588.180]
Carcinoma, Ductal, Breast [C04.588.180.390]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Breast Diseases [C17.800.090]
Breast Neoplasms [C17.800.090.500]
Carcinoma, Ductal, Breast [C17.800.090.500.390]

Below are MeSH descriptors whose meaning is related to "Carcinoma, Ductal, Breast".

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Ductal, Breast".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Ductal, Breast" by people in this website by year, and whether "Carcinoma, Ductal, Breast" was a major or minor topic of these publications.

Bar chart showing 446 publications over 28 distinct years, with a maximum of 35 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
1994	5	5	10
1995	3	4	7
1996	7	0	7
1997	7	4	11
1998	7	2	9
1999	3	4	7
2000	5	5	10
2001	15	2	17
2002	13	3	16
2003	10	3	13
2004	5	4	9
2005	15	3	18
2006	14	7	21
2007	12	10	22
2008	18	7	25
2009	14	6	20
2010	22	6	28
2011	20	6	26
2012	27	8	35
2013	16	3	19
2014	20	4	24
2015	20	2	22
2016	11	7	18
2017	15	2	17
2018	10	3	13
2019	9	6	15
2020	4	2	6

Below are the most recent publications written about "Carcinoma, Ductal, Breast" by people in Profiles.

Weaver O, Yang W. Imaging of Breast Cancers With Predilection for Nonmass Pattern of Growth: Invasive Lobular Carcinoma and DCIS-Does Imaging Capture It All? AJR Am J Roentgenol. 2020 12; 215(6):1504-1511.

View in: PubMed
Minami CA, Kantor O, Weiss A, Nakhlis F, King TA, Mittendorf EA. Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer. J Am Coll Surg. 2020 10; 231(4):434-447.e2.

View in: PubMed
Guo H, Ding Q, Gong Y, Gilcrease MZ, Zhao M, Zhao J, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo L. Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors. Breast Cancer Res. 2020 06 23; 22(1):69.

View in: PubMed
Iwase T, Harano K, Masuda H, Kida K, Hess KR, Wang Y, Dirix L, Van Laere SJ, Lucci A, Krishnamurthy S, Woodward WA, Layman RM, Bertucci F, Ueno NT. Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC. BMC Cancer. 2020 May 18; 20(1):430.

View in: PubMed
Brown TA, Mittendorf EA, Hale DF, Myers JW, Peace KM, Jackson DO, Greene JM, Vreeland TJ, Clifton GT, Ardavanis A, Litton JK, Shumway NM, Symanowski J, Murray JL, Ponniah S, Anastasopoulou EA, Pistamaltzian NF, Baxevanis CN, Perez SA, Papamichail M, Peoples GE. Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence. Breast Cancer Res Treat. 2020 Jun; 181(2):391-401.

View in: PubMed
Chun YS, Mizuno T, Cloyd JM, Ha MJ, Omichi K, Tzeng CD, Aloia TA, Ueno NT, Kuerer HM, Barcenas CH, Vauthey JN. Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes. Eur J Surg Oncol. 2020 09; 46(9):1588-1595.

View in: PubMed
Ghaderi KF, Phillips J, Perry H, Lotfi P, Mehta TS. Contrast-enhanced Mammography: Current Applications and Future Directions. Radiographics. 2019 Nov-Dec; 39(7):1907-1920.

View in: PubMed
Sun SX, Kuerer HM. ASO Author Reflections: Selecting Patients for Elimination of Surgery Trials-Predicting Residual Invasive and In Situ Disease in Patients with HER2-Positive Breast Cancer After Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2019 Dec; 26(Suppl 3):804-805.

View in: PubMed
Kapoor MM, Patel MM, Scoggins ME. The Wire and Beyond: Recent Advances in Breast Imaging Preoperative Needle Localization. Radiographics. 2019 Nov-Dec; 39(7):1886-1906.

View in: PubMed
Weiss A, Wong S, Golshan M, Freedman RA, Metzger O, Bellon J, Mittendorf EA, King TA. Patterns of Axillary Management in Stages 2 and 3 Hormone Receptor-Positive Breast Cancer by Initial Treatment Approach. Ann Surg Oncol. 2019 Dec; 26(13):4326-4336.

View in: PubMed

People

Explore

Similar Concepts

Top Journals